Tricky regulations stir up questions about what constitutes overpayment and when disclosure is needed
If there is insufficient address information for the individual, you also must post the breach on your Web site or publish it with major print or broadcast media. Additionally, you must notify the secretary of Health and Human Services (HHS).
If the breach involves more than 500 individuals, the notice must be sent immediately to HHS and will be posted on the HHS Web site. If the breach concerns fewer than 500 individuals, then you may submit an annual log of the breach with all other breaches you may have experienced in that year.
Perhaps the most significant disclosure requirement facing providers today is when to disclose overpayments, wrongful billing, noncompliance, or fraud of the Medicare and Medicaid programs, including the wrongful employment of excluded persons, and the anti-kickback statute and physician anti-referral laws (Stark laws). Due to the evolving nature of these laws, providers and compliance officers are challenged every day to determine when and to where to disclose noncompliance.
OVERPAYMENT GRAY AREA
For example, the 1998 OIG SDP set forth how to disclose a problem with Medicare billing that is significant enough to be a violation of the law. The question remains as to the gray area between what constitutes an overpayment and when a matter requires self-disclosure. To further complicate the matter, the OIG in 2006 and 2008 encouraged providers to use self-disclosure protocol (SDP) for Stark violations.
However, in 2009, the OIG stated that the SDP should only be used for a Stark violation if there is also an anti-kickback violation. There appears to be no formal process for disclosing Stark violations, which do not have an anti-kickback violation. Government representatives recently suggested at a national conference that these claims can be brought to your U.S. Attorney. Unlike the SDP, there is no protocol to assist a provider with the process and the possible outcomes related to self-disclosure.
If you become aware of a breach of privacy or any of the billing regulations, including fraud and abuse and Stark, evaluate all of your options regarding disclosure. Always conduct a thorough investigation and audit of the situation under the attorney/client privilege in order to fully assess the penalties that may be imposed. Research any possible laws, rules, regulations, or guidance that might help your position concerning perceived noncompliance.
Anthea R. Daniels is a Calfee, Halter & Griswold LLP partner.
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 28th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More